Innovent Biologics

China-based biopharma. Mazdutide (dual GCG/GLP-1) approved by China NMPA June 2025 for chronic weight management; first dual GCG/GLP-1 agonist globally. Partnership with Eli Lilly.

$1801.HKSuzhou, China5,000Biotechnologyinnoventbio.com

SectorsGLP-1

Stock Price - 1801.HK

Founded: 2011 - IPO: 2018

Outstanding Shares

Basic shares represent total shares issued. Diluted shares include potential shares from stock options, convertible securities, and other equity awards.

H1 2016 — H2 2025

Innovent Biologics

Compare Innovent Biologics…

China-based biopharma. Mazdutide (dual GCG/GLP-1) approved by China NMPA June 2025 for chronic weight management; first dual GCG/GLP-1 agonist globally. Partnership with Eli Lilly.

$1801.HKSuzhou, China5,000Biotechnologyinnoventbio.com

SectorsGLP-1

Stock Price - 1801.HK

Founded: 2011 - IPO: 2018

Outstanding Shares

Basic shares represent total shares issued. Diluted shares include potential shares from stock options, convertible securities, and other equity awards.

H1 2016 — H2 2025

Ask Sterling

Innovent Biologics

Stock Price - 1801.HK

Outstanding Shares

Innovent Biologics

Stock Price - 1801.HK

Outstanding Shares